{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:12:11Z","timestamp":1791396731080,"version":"4.3.3"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007332","name":"Autism Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.psychres.2025.116646","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:31:18Z","timestamp":1752852678000},"page":"116646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report"],"prefix":"10.1016","volume":"351","author":[{"given":"Rebecca","family":"Biagetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Giuva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Pirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bergonzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Caramaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Spezia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Iughetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lupetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-4479","authenticated-orcid":false,"given":"Antonio M.","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116646_bib0001","article-title":"Clozapine-induced myocarditis: a case report of an adolescent boy with intellectual disability","volume":"2015","author":"Aboueid","year":"2015","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/cap.2021.0092","article-title":"Clozapine for management of childhood and adolescent-Onset schizophrenia: a systematic review and meta-analysis","volume":"32","author":"Adnan","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2014.07.103","article-title":"A systematic review of clozapine induced cardiomyopathy","volume":"176","author":"Alawami","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2025.116646_bib0004","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/jmri.21988","article-title":"Cardiovascular magnetic resonance in mild to moderate clozapine-induced myocarditis: is there a role in the absence of electrocardiographic and echocardiographic abnormalities?","volume":"31","author":"Ariyarajah","year":"2010","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.psychres.2025.116646_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00023210-200721020-00003","article-title":"Monitoring the safe use of clozapine","volume":"21","author":"Berk","year":"2007","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2025.116646_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40266-013-0144-2","article-title":"Adverse effects of clozapine in older patients: epidemiology, prevention and management","volume":"31","author":"Bishara","year":"2014","journal-title":"Drugs Ag."},{"key":"10.1016\/j.psychres.2025.116646_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0000000000000407","article-title":"Successful clozapine rechallenge after myopericarditis: a case report","volume":"37","author":"Boscutti","year":"2022","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0008","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/1044546041649039","article-title":"Pericarditis and polyserositis as a side effect of clozapine in an adolescent girl","volume":"14","author":"Branik","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0009","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.psychres.2025.116646_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/cap.2022.0075","article-title":"Letter to the editor: delayed fibrosis and late course magnetic resonance imaging findings in clozapine-induced myocarditis in an adolescent","volume":"33","author":"Byeman","year":"2023","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/cap.2013.0098","article-title":"Successful rechallenge of clozapine therapy following previous clozapine-induced myocarditis confirmed on cardiac MRI","volume":"24","author":"Chow","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0012","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2024.02.005","article-title":"Identification and treatment of individuals with childhood-onset and early-onset schizophrenia","volume":"82","author":"Correll","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0014","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.09l05692yel","article-title":"Clozapine rechallenge following clozapine-induced pericarditis","volume":"71","author":"Crews","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0015","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"Davis","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0016","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.rpsm.2021.07.004","article-title":"Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: focus on reports from various countries","volume":"15","author":"De Las Cuevas","year":"2022","journal-title":"Rev. Psiquiatr. Salud. Ment. (Engl. Ed)"},{"key":"10.1016\/j.psychres.2025.116646_bib0017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/acps.12421","article-title":"Titrating clozapine amidst recommendations proposing high myocarditis risk and rapid titrations","volume":"132","author":"De Leon","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116646_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jpsychires.2020.02.026","article-title":"Clozapine in bipolar disorder: a systematic review and meta-analysis","volume":"125","author":"Delgado","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0019","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/JCP.0000000000001923","article-title":"Effect of valproate coprescription on clozapine pharmacokinetics in clinical practice","volume":"44","author":"Flanagan","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0020","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/appi.ajp.157.6.982","article-title":"Clozapine in the treatment of refractory psychotic mania","volume":"157","author":"Green","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0021","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0000000000001358","article-title":"Clozapine-associated myocarditis: a protocol for monitoring upon Clozapine initiation and recommendations for how to conduct a Clozapine rechallenge","volume":"41","author":"Griffin","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0022","series-title":"Clinical Global Impressions ECDEU Assessment Manual For Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.psychres.2025.116646_bib0023","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-200730010-00005","article-title":"Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003","volume":"30","author":"Haas","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.psychres.2025.116646_bib0024","first-page":"e252","article-title":"Clozapine-induced myocarditis and subsequent rechallenge: a narrative literature review and case report","volume":"32","author":"Halawa","year":"2023","journal-title":"J. Can. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3371\/1935-1232-10.2.120","article-title":"Rapid rechallenge with clozapine following pronounced myocarditis in a treatment-resistant schizophrenia patient","volume":"10","author":"Ittasakul","year":"2016","journal-title":"Clin. Schizophr. Relat. Psychoses."},{"key":"10.1016\/j.psychres.2025.116646_bib0028","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.ijcard.2006.01.033","article-title":"Clozapine induced myocarditis: a rare but fatal complication","volume":"112","author":"Kakar","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2025.116646_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2024.01.035","article-title":"Clozapine in treatment-resistant schizophrenia: reflections from the Hallmark US clinical trial and beyond","volume":"268","author":"Kane","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116646_bib0031","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1440-1614.2002.0988f.x","article-title":"Clozapine associated pericarditis and elevated troponin I","volume":"36","author":"Kay","year":"2002","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004027.pub2","article-title":"Antipsychotic medication for childhood-onset schizophrenia","author":"Kennedy","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2025.116646_bib0033","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2017.03.013","article-title":"Clozapine and incidence of myocarditis and sudden death \u2013 Long term Australian experience","volume":"238","author":"Khan","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2025.116646_bib0034","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116646_bib0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/JCP.0000000000000922","article-title":"Hepatitis, interstitial nephritis, and pancreatitis in association with clozapine treatment: a systematic review of case series and reports","volume":"38","author":"Lally","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0036","article-title":"Treatment-resistant schizophrenia: evaluation and management","volume":"26","author":"Lim","year":"2024","journal-title":"Prim. Care Companion. CNS. Disord."},{"key":"10.1016\/j.psychres.2025.116646_bib0037","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2011.10.014","article-title":"When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature","volume":"134","author":"Manu","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0038","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.euroneuro.2023.04.003","article-title":"Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: a meta-analysis","volume":"73","author":"Martins","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0039","doi-asserted-by":"crossref","first-page":"123","DOI":"10.24869\/psyd.2024.123","article-title":"Clozapine-induced myocarditis: an adolescent girl with very early-onset schizophrenia","volume":"36","author":"Mutlu","year":"2024","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.psychres.2025.116646_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","article-title":"Practice parameter for the assessment and treatment of children and adolescents with cchizophrenia","volume":"52","author":"McClellan","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0041","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00277-020-04215-y","article-title":"Clozapine-induced agranulocytosis","volume":"99","author":"Mijovic","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.psychres.2025.116646_bib0042","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/a-1811-7318","article-title":"Clinical outcomes after clozapine discontinuation in patients with schizophrenia: a systematic review","volume":"55","author":"Miura","year":"2022","journal-title":"PharmacoPsychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0043","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/JCP.0000000000000967","article-title":"Myocarditis during treatment with clozapine in 2 adolescent cases","volume":"38","author":"Mudra","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0044","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1039856217707394","article-title":"Successful clozapine re-challenge following myocarditis","volume":"25","author":"Nguyen","year":"2017","journal-title":"Australas. Psychiatry"},{"issue":"372","key":"10.1016\/j.psychres.2025.116646_bib0045","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116646_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4245","article-title":"Antipsychotic drugs and risk of venous thromboembolism: nested case-control study","volume":"341","author":"Parker","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116646_bib0047","doi-asserted-by":"crossref","unstructured":"Pattnaik, J.I., Panda, U.K., Chandran, S., Padhy, S., Ravan, J.R., 2023. Treatment resistant psychosis in children and adolescents and clozapine: nuances Front Psychiatry. 14, 1014540. https:\/\/doi.org\/10.3389\/fpsyt.2023.1014540.","DOI":"10.3389\/fpsyt.2023.1014540"},{"key":"10.1016\/j.psychres.2025.116646_bib0048","first-page":"133","article-title":"Clozapine-induced pericarditis: an overlooked adverse effect","volume":"8","author":"Paul","year":"2014","journal-title":"Clin. Schizophr. Relat. Psychoses."},{"key":"10.1016\/j.psychres.2025.116646_bib0049","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40263-024-01100-4","article-title":"When, why and how to re-challenge clozapine in schizophrenia following myocarditis","volume":"38","author":"Qubad","year":"2024","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2025.116646_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000096666","article-title":"Clozapine-induced effuso-constrictive pericarditis","volume":"108","author":"Rathore","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.psychres.2025.116646_bib0051","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/schbul\/20.4.727","article-title":"Childhood-onset schizophrenia: history of the concept and recent studies","volume":"20","author":"Remschmidt","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116646_bib0052","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.rpsm.2020.05.003","article-title":"Clozapine in patients with schizoaffective disorder: a systematic review","volume":"14","author":"Rey Souto","year":"2021","journal-title":"Rev. Psiquiatr. Salud Ment. Engl. Ed."},{"key":"10.1016\/j.psychres.2025.116646_bib0053","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40263-017-0461-9","article-title":"Cardiovascular disease in clozapine-treated patients: evidence, mechanisms and management","volume":"31","author":"Ronaldson","year":"2017","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2025.116646_bib0054","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2011.01.017","article-title":"Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases","volume":"128","author":"Ronaldson","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0055","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0056","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2012.08.018","article-title":"Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case\u2013control study","volume":"141","author":"Ronaldson","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0057","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4088\/JCP.11l07467","article-title":"Observations from 8 cases of clozapine rechallenge after development of myocarditis","volume":"73","author":"Ronaldson","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0058","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/0004867411433970","article-title":"Continuation of clozapine following mild myocarditis","volume":"46","author":"Ronaldson","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0059","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116646_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.9740\/mhc.2018.11.313","article-title":"Clozapine-induced myocarditis in an adolescent male with DiGeorge Syndrome","volume":"8","author":"Ruhe","year":"2018","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.psychres.2025.116646_bib0061","first-page":"1055","article-title":"A Dutch guideline for the use of Clozapine","volume":"44","author":"Schulte","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0062","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1192\/bjp.2021.58","article-title":"Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy","volume":"219","author":"Segev","year":"2021","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116646_bib0063","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40263-023-01054-z","article-title":"Evaluating monitoring guidelines of clozapine-induced adverse effects: a systematic review","volume":"38","author":"Smessaert","year":"2024","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2025.116646_bib0064","doi-asserted-by":"crossref","first-page":"618","DOI":"10.24953\/turkjped.2019.04.024","article-title":"Complete atrioventricular block associated with clozapine intoxication: case report","volume":"61","author":"T\u00fcre","year":"2019","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.psychres.2025.116646_bib0065","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.schres.2023.09.039","article-title":"The cellular mechanism of antipsychotic-induced myocarditis: a systematic review","volume":"261","author":"Vaziri","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116646_bib0066","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/acps.12896","article-title":"Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines","volume":"138","author":"Verdolini","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116646_bib0067","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/acps.13398","article-title":"Risk factors for clozapine-induced myocarditis and cardiomyopathy: a systematic review and meta-analysis","volume":"145","author":"Vickers","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2025.116646_bib0068","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00023210-200317040-00004","article-title":"Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder","volume":"17","author":"Wagstaff","year":"2003","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2025.116646_bib0069","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2710.2004.00616_1.x","article-title":"Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine","volume":"30","author":"Wehmeier","year":"2005","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.psychres.2025.116646_bib0070","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320924786","article-title":"Resolution without discontinuation: heart failure during clozapine treatment","volume":"10","author":"Whiskey","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116646_bib0071","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","article-title":"Management of the adverse effects of clozapine","volume":"24","author":"Young","year":"1998","journal-title":"Schizophr. Bull."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812500294X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812500294X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:35:29Z","timestamp":1778945729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812500294X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":69,"alternative-id":["S016517812500294X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116646","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-induced cardiac toxicity and successful rechallenge in children and adolescents: a systematic review and new case report","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116646"}}